Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy

This study has been completed.
Sponsor:
Information provided by:
Cellectar Biosciences, Inc.
ClinicalTrials.gov Identifier:
NCT00372983
First received: September 5, 2006
Last updated: December 17, 2007
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2007
  Estimated Primary Completion Date: No date given